一个高保真度的CRISPR-Cas13系统改善了与C9ORF72相关的ALS/FTD相关的异常
Tristan X McCallister1, Colin K W Lim1, William M Terpstra1
1Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
bioRxiv : the preprint server for biology
|January 3, 2024
概括
一种新型的RNA向CRISPR系统有效地减少了对肌缩侧面硬化症 (ALS) 和前性痴呆症 (FTD) 的小鼠模型中的有毒RNA. 这种方法为C9ORF72相关的神经退行性疾病提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 肌缩侧面硬化症 (ALS) 和前性痴呆症 (FTD) 与GGGGCC在C9ORF72基因中的重复扩张有关.
- 涉及重复含有RNA的功能获取机制有助于这些疾病中的神经退行.
结论:
- 这种向RNA的CRISPR平台为开发针对C9ORF72相关的ALS和FTD的新疗法提供了基础.
- 这项研究强调了基于CRISPR的基因调控对神经退行性疾病的潜力.
相关概念视频
CRISPR
51.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.2K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K


